Fast reading :

• Employing more than 15,000 people across 58 countries, Ansell’s products are sold in over 100 countries and across 25 industries. Within healthcare, its portfolio covers surgical gloves, single-use and examination gloves and products for those working within life-science companies. Within its industrials portfolio, the company provides high-performance safety gloves and chemical-protection clothing for workers across a wide range of industries including automotives, oil and gas.
• Ansell has a diversified revenue base across end markets and regions with significant further growth opportunities as regulators enforce more stringent rules around worker safety and protection.
• The company is highly cashflow generative with strong cash conversion. As a result, it is able to invest in manufacturing capacity while also engaging in M&A (most recently in clean-room protection) and simultaneously providing returns to shareholders.

Ansell has committed to net neutral emissions in its operations by 2040 with a mid-term target of a 42% reduction by 2030. Furthermore, Ansell has formally committed to the SBTi and will therefore soon be setting science-based net-zero targets which encapsulate its value chain.

Learn more here